BIO
Bio-Rad Laboratories, Inc.
Stock
$369.14+13.57 (+3.82%)Close Oct 2, 2026
- EBITDA, 2025
- $213M
- YoY, 2025
- −49.5%
- 5-year CAGR
- −17.6%
- 10-year CAGR
- −3.3%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $213M | −49.5% |
| 2024 | $421M | −13.0% |
| 2023 | $484M | −22.0% |
| 2022 | $620M | −2.8% |
| 2021 | $638M | +13.9% |
| 2020 | $560M | +53.9% |
| 2019 | $364M | +946.8% |
| 2018 | $35M | −87.0% |
| 2017 | $268M | +34.9% |
| 2016 | $199M | −33.5% |
| 2015 | $299M | −0.5% |
| 2014 | $300M | −5.3% |
| 2013 | $317M | −19.7% |
| 2012 | $395M | −7.4% |
| 2011 | $426M | +8.5% |
| 2010 | $393M | +18.1% |
| 2009 | $333M | — |